0 CHECKOUT

China Proton Therapy Outlook 2020

  • ID: 3494093
  • November 2015
  • Region: China
  • 70 pages
  • RNCOS E-Services Private Limited
1 of 4

FEATURED COMPANIES

  • Advanced Oncotherapy
  • IBA
  • ProNova Solutions, LLC
  • Siemens Healthcare GmbH
  • MORE

Owing to the the growth in the cancer incidences in China, various technologically advanced therapies are now being introduced in the country. One such adavnced technology is the, Proton Therapy, which is one of the most advanced radiation technique available today. Unfortunately, the access to proton therapy is limited for a vast population, owing to a low number of proton therapy centers. Hence, many research institutions and hospitals have now started investing in proton therapy to make it more accessible to patients.

According to the “China Proton Therapy Outlook 2020” report by 2020, China will have nine proton therapy centers. Consequently, the market will attain revenue of around US$ 165 Million by 2020, growing at a CAGR of 68% during the forecast period (2015-2020). The report also provides an insight into the cancer demographics of China and the various possible reasons for a high cancer incidence in the country.

Based on a complex correlation-regression model accounting population demographics, disease statistics, macro & micro economic indicators of the country, etc. The report provides potential market in China. The report also includes the READ MORE >

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Advanced Oncotherapy
  • IBA
  • ProNova Solutions, LLC
  • Siemens Healthcare GmbH
  • MORE

1. Analyst View

2. Research Methodology

3. China Cancer Demographics
3.1 Incidence by Site

4. Current Radiation Therapies
4.1 Third Dimensional Conformal Therapy (CRT)
4.2 Image Guided Radiotherapy (IGRT)
4.3 Intensity Modulated Radiotherapy (IMRT)
4.4 Stereotactic Radiotherapy
4.5 Neutron Therapy
4.6 Heavy Ion Radiotherapy
4.7 Proton Therapy
4.7.1 Need for Proton Therapy

5. Components of a Standard Proton Therapy Center
5.1 Proton Accelerator
5.2 Beam Transport System
5.3 Beam Delivery System
5.4 Nozzle
5.4.1 Single Scattering
5.4.2 Double Scattering
5.4.3 Uniform Scanning Nozzle
5.4.4 Pencil Scanning Nozzle
5.5 Treatment Planning System
5.6 Image Viewers
5.7 Patient Positioning System
5.8 Human Resource

6. China Proton Therapy Market
6.1 Current Market Size and Future Growth
6.2 Potential Patients
6.2.1 Market Penetration
6.3 Opportunity Assessment
6.4 Existing and Forthcoming Players Analysis
6.4.1 Service Providers
6.4.2 Equipment Providers
6.5 Proton Therapy Centers Analysis

7. Market Dynamics
7.1 Drivers
7.1.1 Increasing Incidence of Cancer
7.1.2 Benefits of Proton Therapy over Conventional Therapies
7.1.3 Rising investment for Proton Therapy in China
7.1.4 Technological Advancements
7.2 Restraints
7.2.1 High Cost of Treatment
7.2.2 Reimbursement Issues
7.3 Opportunity
7.3.1 Medical Tourism in China

8. Market Trends
8.1 Centers with Large Number of Treatment Rooms

9. Competitive Landscape and Strategic Analysis
9.1 IBA
9.2 Sumitomo Heavy Industries, Ltd.
9.3 ProNova Solutions, LLC
9.4 Advanced Oncotherapy
9.5 Siemens Healthcare GmbH

List of Tables
Table 3-1: Cancer Incidence Growth by Site (2015-2035)
Table 5-1: Human Resource Requirements and their Role in Proton Therapy Center
Table 6-1: Potential Patients for Proton Therapy (2015 & 2020)
Table 6-2: Proton Therapy Centers (2015)
Table 6-3: Upcoming Proton Therapy Centers (2016 - 2020)
Table 6-4: Proton Therapy Equipment Providers with Number of Installations, (2015)
Table 6-5: Proton Therapy Equipment Providers with Number of Installations by 2020
Table 9-1: IBA - Proton Therapy Products and Services
Table 9-2: IBA - Key Financials (Million US$), 2012-2014
Table 9-3: IBA - Proton Therapy Installations in China
Table 9-4: IBA – Upcoming Proton Therapy Installations in China
Table 9-5: IBA - Strengths and Weaknesses
Table 9-6: Sumitomo - Key Financials (Million US$), 2013-2015
Table 9-7: Sumitomo – Upcoming Proton Therapy Installations in China
Table 9-8: Sumitomo - Strengths and Weaknesses
Table 9-9: Pronova – Upcoming Proton Therapy Installations in China
Table 9-10: Pronova – Strengths and Weaknesses
Table 9-11: Advanced Oncotherapy - Key Financials (‘000 US$), 2012-2014
Table 9-12: Advanced Oncotherapy - Upcoming Proton Therapy Installations in China
Table 9-13: Advanced Oncotherapy - Strengths and Weaknesses
Table 9-14: Siemens - Key Financials (Million US$), 2012-2014
Table 9-15: Siemens –Proton Therapy Installations in China
Table 9-16: Siemens – Strengths and Weaknesses

List of Figures
Figure 4-1: Advantages of Proton Therapy over Conventional Radiation Therapy
Figure 5-1: Components of a Proton Therapy Center
Figure 6-1: Proton Therapy Market (Million US$), 2015-2020
Figure 6-2: Share of Proton Therapy Market in Potential Market (%), 2015
Figure 6-3: Share of Proton Therapy Market in Potential Market (%), 2020
Figure 6-4: Demand of Proton Therapy Centers (2015 & 2020)
Figure 6-5: Shortage of Proton Therapy Centers (2015 & 2020)
Figure 6-6: Share of Vendors by Number of Proton Accelerators Installed (%), 2015
Figure 6-7: Share of Vendors by Number of Proton Accelerators Installed (%), 2020
Figure 7-1: Cancer Incidence (Million), 2012 to 2035
Figure 8-1: Proton Therapy Center by Number of Treatment Rooms (2015 & 2020)
Figure 9-1: IBA - Breakdown of Revenue by Activity (%), 2014

Note: Product cover images may vary from those shown
3 of 4

- Advanced Oncotherapy
- IBA
- ProNova Solutions, LLC
- Siemens Healthcare GmbH
- Sumitomo Heavy Industries, Ltd.

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PURCHASING OPTIONS

HAVE A QUESTION?

EMAIL US VIEW FAQs

RELATED PRODUCTS from Db

Our Clients

  • AB Sciex
  • Eli Lilly and Company
  • B. Braun Melsungen AG
  • Astellas Pharma, Inc.
  • Hologic Inc.
  • Merck & Co., Inc.